Categories: All postsCannabis

Cronos Group is looking fully valued, GMP Securities says

Following a run-up in its share price, GMP Securities analyst Martin Landry thinks Cronos Group (Cronos Group Stock Quote, Chart, News: TSXV:MJN) is looking fully valued at current levels.

On Wednesday, Cronos Group announced the closing of a bought deal financing that saw the company raise approximately $46-million. The offering was underwritten by a syndicate led by PI Financial Corp. and included GMP Securities, Beacon Securities, and Cormark Securities.

In a research update to clients today, Landry resumed coverage of the stock. The analyst simultaneously raised his price target on Cronos, from $4.50 to $11.00, but lowered his rating on it, from “Buy” to “Hold”. His new target implied a return of 1.5 per cent at the time of publication.

Landry says there is a lot to like about Cronos, just not at its current share price, which has more than quadrupled since September.

“We like MJN’s growth profile with a large domestic capacity expansion, and a strong international platform, the analyst says. “However with shares trading at ~17x CY19 sales, MJN’s valuation is the highest amongst peers under coverage based on our forecasts, and adequately reflects the bright outlook. Hence our downgrade is mainly based on valuation which we would revisit pending a pullback in share price. Our target is based on a DCF using: 1) a discount rate of 9.5% (10% prior), (2) avg. market share of 4% and avg. EBITDA margin of 30% (32% prior), and (3) terminal growth of 3%.

Landry thinks Cronos Group will generate EBITDA of negative $3.2-million on revenue of $4.5-million in fiscal 2017. He expects those numbers will improve to EBITDA of positive $19.2-million on a topline of $64.3-million the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 days ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 days ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

2 days ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

3 days ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

3 days ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

3 days ago